According to Cancer Research UK, there are around 6,600 new liver cancer cases in the UK every year, and around 5,830 people ...

Among the 62 patients with unresectable or metastatic HER2-positive (IHC 3+) disease, zanidatamab monotherapy induced ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...

Learn how personalised treatments are providing new hope with tailored therapies offering better outcomes for patients ...

Learn about HMGB1's crucial role in liver diseases, its pathways and therapeutic potential that can treat liver diseases.

Liver diseases, both acute and chronic ... plays a role in hepatocellular carcinoma (HCC), influencing tumor proliferation, ...